Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 5 | 2023 | 706 | 1.850 |
Why?
|
| End Stage Liver Disease | 3 | 2023 | 63 | 1.790 |
Why?
|
| Tissue and Organ Procurement | 2 | 2023 | 228 | 1.410 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 541 | 1.140 |
Why?
|
| Transplant Recipients | 2 | 2024 | 140 | 0.990 |
Why?
|
| Living Donors | 5 | 2023 | 270 | 0.780 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 182 | 0.770 |
Why?
|
| Alzheimer Disease | 3 | 2019 | 443 | 0.320 |
Why?
|
| Retrospective Studies | 6 | 2024 | 12515 | 0.310 |
Why?
|
| Registries | 2 | 2024 | 1759 | 0.260 |
Why?
|
| Cytomegalovirus | 1 | 2024 | 144 | 0.210 |
Why?
|
| Waiting Lists | 1 | 2023 | 211 | 0.190 |
Why?
|
| Graft Survival | 1 | 2023 | 452 | 0.180 |
Why?
|
| Cholestasis | 1 | 2023 | 224 | 0.170 |
Why?
|
| United States | 3 | 2023 | 12176 | 0.160 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 2539 | 0.160 |
Why?
|
| tau Proteins | 1 | 2019 | 69 | 0.160 |
Why?
|
| Immunity | 1 | 2019 | 121 | 0.150 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 69 | 0.150 |
Why?
|
| Quality Control | 1 | 2018 | 144 | 0.150 |
Why?
|
| Humans | 11 | 2024 | 114757 | 0.150 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 94 | 0.150 |
Why?
|
| Genetic Loci | 1 | 2019 | 263 | 0.150 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 26 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 189 | 0.140 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 201 | 0.130 |
Why?
|
| Microglia | 1 | 2017 | 202 | 0.130 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 1197 | 0.120 |
Why?
|
| Liver | 1 | 2023 | 1631 | 0.120 |
Why?
|
| Lipids | 1 | 2019 | 582 | 0.120 |
Why?
|
| Prognosis | 1 | 2023 | 3334 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 429 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 368 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 152 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 2099 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2023 | 9089 | 0.100 |
Why?
|
| Adult | 2 | 2024 | 30548 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 728 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2017 | 723 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 1133 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 1892 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2022 | 3005 | 0.080 |
Why?
|
| DNA | 1 | 2014 | 1351 | 0.080 |
Why?
|
| Genotype | 2 | 2018 | 1774 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 208 | 0.050 |
Why?
|
| Catheterization | 1 | 2023 | 160 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 182 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 34 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 453 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 245 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 353 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2019 | 379 | 0.030 |
Why?
|
| Exome | 1 | 2017 | 200 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 481 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 446 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 612 | 0.030 |
Why?
|
| Programming Languages | 1 | 2014 | 22 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 954 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 1988 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 1468 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1521 | 0.020 |
Why?
|
| Male | 3 | 2022 | 55579 | 0.020 |
Why?
|
| Female | 3 | 2022 | 59507 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 19094 | 0.010 |
Why?
|